Ori and MaxCyte have selected CD19 CAR expression via CRISPR knock-in in activated T cells as the test system for initial evaluation.

All of us produce a growth factor—called IL-15—which effectively protects us from cancers. Its role is to boost the ...

CRISPR-Cas13, a powerful RNA-targeting technology is gaining increasing attention as a next-generation gene therapy platform due to its precision and reduced side effects.

Over the past decade, the emergence of advanced therapy medicinal products (ATMPs) has fundamentally changed the approach to ...

Industry experts weigh in on current trends, challenges, and the future of the cell and gene therapy CDMO market. Cell and gene therapies, which fall under the general classification of advanced ...

Precision gene editing is crucial for treating genetic diseases, as it enables targeted correction of specific mutations.

An Emirati man with a rare inherited disorder has become only the second patient in the world to benefit from a pioneering $2 ...

Capsida is initiating the Phase 1/2 study for CAP-003, with the first patient expected to be dosed in the third quarter of this year ...